Le Lézard
Classified in: Health, Covid-19 virus
Subjects: AVO, CPG, CMG, CFG

CMA CALLING FOR RAPID ACTION, GREATER COLLABORATION AND CLEARER COMMUNICATION IN FACE OF COVID-19


OTTAWA, ON, Jan. 11, 2022 /CNW/ - The Canadian Medical Association (CMA) is appealing to federal, provincial and territorial governments to work together to minimize the impact of the current wave of COVID-19 using the tools, experience, and expertise gained from the last two years of the pandemic. The CMA is concerned that the latest wave coursing through the country may leave the health system unable to recover.

"We have gone back in time to overwhelmed hospitals, cancelled surgeries and testing. Most schools across the country are closed for in-person learning, and there is a growing labour shortage. Health care workers have reached the limit of burnout and exhaustion," says Dr. Katharine Smart, CMA President. "We must now double down on using tools and experience to blunt the impact of Omicron and plan for future waves."

The CMA believes Canada can mitigate the pandemic by: 

"We know Canadians are tired and frustrated. Physicians, nurses, respiratory therapists, pharmacists, laboratory technologists and other health care providers are beyond exhausted right now. And we need all hands-on deck to stabilize our health system to care for COVID patients and all others requiring care," says Dr. Smart.

About the CMA
The Canadian Medical Association is the national voice of the medical profession. Our focus is on creating strong and accessible health systems, fostering well-being and diversity in medical culture, and ensuring every person in Canada has equal opportunity to be healthy. In partnership with physicians, medical learners, patients and others, we advance these goals through advocacy, knowledge sharing and granting.

SOURCE Canadian Medical Association


These press releases may also interest you

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 17:15
Amgen and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of baseline blood...

18 mai 2024
Emmy-winning actor and St. Louis native Jon Hamm took the stage Saturday, May 18, to offer words of wisdom to the newest graduates of Saint Louis University (SLU) during the University's spring commencement in St. Louis. ...

18 mai 2024
Nearly 900 undergraduates of the Class of 2024 celebrated their send-off from Bentley University in a very different way than their 2020 arrival amid the COVID-19 pandemic. The 105th undergraduate commencement ceremony was marked by maskless smiles,...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: